Robert Lawrence Camp PhD, MD

Associate Research Scientist in Pathology

Research Interests

Quantitative Pathology; Prognostic markers in breast cancer; Phenotypic differences between primary and metastatic breast cancer; Growth factor responsiveness of breast carcinoma; Tissue microarrays; Automated analysis of immunohistochemistry

Extensive Research Description

Prognostic markers in breast cancer;
Phenotypic differences between primary and metastatic breast cancer;
Growth factor responsiveness of breast carcinoma;
Tissue microarrays;
Automated analysis of immunohistochemistry


Selected Publications

  • Camp RL, Dolled-Filhart M, King BL, Rimm DL. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res. 2003 Apr 163(7):1445-8.
  • Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin CY, Dickson RB, Rimm DL,Camp RL. Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res. 2003 Mar 163(5):1101-5.
  • Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002 Nov8(11):1323-7.
  • Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000 Dec80(12):1943-9.
  • Camp RL, Rimm EB, Rimm DL. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer. 1999 Dec 186(11):2259-65.
  • Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors. Cancer. 2003 Apr 1597(8):1841-8.
  • Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol. 2001 Jun70(3):255-64. Review.
  • Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M. Tissue microarray: a new technology for amplification of tissue resources. Cancer J. 2001 Jan-Feb7(1):24-31. Review.

Edit Profile